David-Alexandre C. Gros

CIK: 0001644489

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (80.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ELDN

Eledon Pharmaceuticals, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

ELDN
Eledon Pharmaceuticals, Inc.
Jul 31, 2026
Award(A)
Direct
354.5K shares-
ELDN
Eledon Pharmaceuticals, Inc.
Jul 31, 2026
Tax Payment(F)
Direct
194.8K shares at avg. $3.38$658K
ELDN
Eledon Pharmaceuticals, Inc.
Jan 10, 2025
Award(A)
Stock Option (right to buy)
Direct
600K shares-
ELDN
Eledon Pharmaceuticals, Inc.
Jan 10, 2025
Award(A)
Restricted Stock Units
Direct
66.5K shares-
ELDN
Eledon Pharmaceuticals, Inc.
Nov 21, 2024
Award(A)
Stock Option (right to buy)
Direct
1M shares-

		Type	Shares	Price		Ownership
Jul 31, 2026	ELDN Eledon Pharmaceuticals, Inc.	Award(A)	354,454	-	$0	Direct
Jul 31, 2026	ELDN Eledon Pharmaceuticals, Inc.	Tax Payment(F)	194,791	$3.38	$658,394	Direct
Jan 10, 2025	ELDN Eledon Pharmaceuticals, Inc.	Award(A) Stock Option (right to buy)	600,000	-	-	Direct
Jan 10, 2025	ELDN Eledon Pharmaceuticals, Inc.	Award(A) Restricted Stock Units	66,500	-	-	Direct
Nov 21, 2024	ELDN Eledon Pharmaceuticals, Inc.	Award(A) Stock Option (right to buy)	1,015,743	-	-	Direct

1-5 of 5 transactions

About Gros David-Alexandre C

Gros David-Alexandre C (SEC CIK 0001644489) files insider reports with the SEC as Chief Executive Officer of Eledon Pharmaceuticals, Inc. (ELDN).

Signal8 holds 3 ownership filings by Gros David-Alexandre C, all Form 4s, filed between Nov 22, 2024 and Aug 4, 2026. Those filings report 5 transactions, from Nov 21, 2024 to Jul 31, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Gros David-Alexandre C's filings is in IRVINE, CA.

Recent filings by Gros David-Alexandre C

Jul 31, 2026: Grant or award of ELDN shares (Form 4, code A).
Jul 31, 2026: Tax withholding of ELDN shares (Form 4, code F).
Jan 10, 2025: Grants or awards of ELDN derivative securities (2 lines, Form 4, code A).
Nov 21, 2024: Grant or award of ELDN derivative securities (Form 4, code A).

Other insiders filing for Eledon Pharmaceuticals, Inc. (ELDN)

Perrin Steven, President
McBride John S., Director
Hillson Jan, Director
Kirk Allan, Director
Katkin Keith, Director
Lee June, Director

How to read Form 4 transaction codes